Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Coronary Artery Disease

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1621824

This article is part of the Research TopicAdvancements in Percutaneous Coronary Intervention: Physiology and Intravascular Imaging GuidanceView all 3 articles

OCT-Based Vulnerable Plaque Features and MACE Prediction in Premature Coronary Artery Disease

Provisionally accepted
Jiabao  LiuJiabao Liu1Haoyu  MengHaoyu Meng1Leilei  ChenLeilei Chen1Lian-Sheng  WangLian-Sheng Wang1Jiayang  XuJiayang Xu2*
  • 1First Affiliated Hospital, Nanjing Medical University, Nanjing, China
  • 2Nanjing Jiangning Hospital of Traditional Chinese Medicine, Nanjing, China

The final, formatted version of the article will be published soon.

Objective: This study aimed to systematically analyze coronary plaque characteristics in patients with premature coronary artery disease (PCAD) using optical coherence tomography (OCT) and clarify their associations with clinical risk factors and major adverse cardiovascular events (MACE). Methods: A total of 224 patients (men≤55 years, women≤65 years) with suspected or confirmed CAD who underwent coronary angiography and OCT at the First Affiliated Hospital of Nanjing Medical University between February 2022 and February 2024 were enrolled. Among them, 142 were diagnosed with PCAD (observation group), and 82 had coronary stenosis <50% (control group). Baseline clinical data, risk factors, and OCT-derived plaque features were collected. Patients were followed for 12 months to record MACE. Statistical analyses included independent t-tests, chi-square tests, and multivariate Cox regression. Results: The PCAD group exhibited significantly higher prevalence rates of hypertension (63.38% vs. 47.56%), smoking (30.28% vs. 17.07%), and diabetes (19.72% vs. 8.54%), along with elevated total cholesterol (4.89±1.41 vs. 4.41±1.32 mmol/L), LDL-C (2.91±0.98 vs. 2.51±0.72 mmol/L), and lipoprotein(a) (50.2±28.4 vs. 30.5± 18.7 mg/dL) compared to controls (all p<0.05). OCT analysis revealed higher vulnerability in PCAD plaques, characterized by thinner fibrous caps (150.16±82.71 vs. 250.71±123.53 µm, p<0.01), larger lipid arc (93.21±36.43° vs. 60.10±24.46°, p<0.01), increased macrophage infiltration (19.01% vs. 4.87%, p<0.01), and more intraplaque microchannels (14.79% vs. 8.53%, p<0.05). During follow-up, MACE incidence was significantly higher in the PCAD group (12.68% vs. 3.70%, p<0.01). Multivariate Cox regression identified thin-cap fibroatheroma (HR=2.95), lipid arc ≥180 ° (HR=2.61), macrophage infiltration (HR=1.98), plaque rupture (HR=2.82), and thrombosis (HR=2.30) as independent predictors of MACE. Conclusion: Patients with PCAD demonstrate distinct coronary plaque vulnerability features closely associated with metabolic and lifestyle-related risk factors. OCT enables precise identification of high-risk plaques, providing critical insights for early intervention and risk stratification to mitigate acute cardiovascular events.

Keywords: premature coronary artery disease (PCAD), optical coherence tomography (OCT), Vulnerable Plaque, Major adverse cardiovascular events (MACE), risk stratification

Received: 02 May 2025; Accepted: 30 Sep 2025.

Copyright: © 2025 Liu, Meng, Chen, Wang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jiayang Xu, koel000@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.